TScan Therapeutics (TCRX) Assets Growth (1y) (2021 - 2026)
TScan Therapeutics (TCRX) Assets Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.29% |
| Dec 31, 2025 | -38.35% |
| Sep 30, 2025 | -24.65% |
| Jun 30, 2025 | -20.36% |
| Mar 31, 2025 | 38.15% |
| Dec 31, 2024 | 36.37% |
| Sep 30, 2024 | 19.44% |
| Jun 30, 2024 | 18.28% |
| Mar 31, 2024 | 38.75% |
| Dec 31, 2023 | 36.70% |
| Sep 30, 2023 | 76.11% |
| Jun 30, 2023 | 107.93% |
| Mar 31, 2023 | 3.19% |
| Dec 31, 2022 | 5.84% |
| Sep 30, 2022 | -19.25% |
| Jun 30, 2022 | 17.24% |
| Dec 31, 2021 | 278.20% |